ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q3 2023 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2023-11-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $20.84M (100.0% shares, 0.0% debt)

Holdings (4)

— RAYZEBIO INC 83.0%

Value $17.29M Shares 778,922 Est. Cost $22.20 Unrealized —

— MEDAVAIL HOLDINGS INC 8.7%

Value $1.804M Shares 300,588 Est. Cost $5.03 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 5.4%

Value $1.121M Shares 1,038,296 Est. Cost $7.36 Unrealized -86.5%

LUNG PULMONX CORP 3.0%

Value $622K Shares 60,204 Est. Cost $48.97 Unrealized -76.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	RAYZEBIO INC	778,922	$17.29M	83.0%	$22.20	—	COM	75525N107
—	MEDAVAIL HOLDINGS INC	300,588	$1.804M	8.7%	$5.03	—	COM	58406B103
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$1.121M	5.4%	$7.36	-86.5%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$622K	3.0%	$48.97	-76.3%	COM	745848101